Published in Am J Med on March 01, 2010
Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep (2015) 1.09
Atrial fibrillation and mortality in heart failure: a community study. Circ Heart Fail (2011) 0.98
Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds. J Biomed Mater Res A (2011) 0.88
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open (2012) 0.87
Atrial fibrillation in heart failure: what should we do? Eur Heart J (2015) 0.86
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation. Europace (2012) 0.82
Atrial fibrillation pacing decreases intravascular shear stress in a New Zealand white rabbit model: implications in endothelial function. Biomech Model Mechanobiol (2012) 0.81
Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction. J Biol Chem (2016) 0.80
Atrial fibrillation in heart failure: an innocent bystander? Curr Cardiol Rev (2012) 0.79
Biological significance of miR-126 expression in atrial fibrillation and heart failure. Braz J Med Biol Res (2015) 0.78
Atrial Fibrillation and Cardiovascular Comorbidities, Survival and Mortality: A Real-Life Observational Study. Cardiol Res (2014) 0.76
A review on atrioventricular junction ablation and pacing for heart rate control of atrial fibrillation. J Geriatr Cardiol (2015) 0.75
Atrial fibrillation management in older heart failure patients: a complex clinical problem. Heart Int (2016) 0.75
Atrial fibrillation in heart failure: The sword of Damocles revisited. World J Cardiol (2013) 0.75
The current approach of atrial fibrillation management. Avicenna J Med (2016) 0.75
Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting. J Cardiovasc Pharmacol Ther (2008) 0.80
Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus. Recent Pat Cardiovasc Drug Discov (2012) 0.75